The putative multidrug resistance protein MRP-7 inhibits methylmercury-associated animal toxicity and dopaminergic neurodegeneration in Caenorhabditis elegans

Journal of Neurochemistry

Volumn 128, Issue 6, 2014, Pages 962-974

  VanDuyn, Natalia ^a   Nass, Richard ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

methylmercury; neurodegeneration; neurotoxicity; Parkinson's disease

Indexed keywords

HEAT SHOCK PROTEIN; METHYLMERCURY; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 7;

ADULT; ARTICLE; CAENORHABDITIS ELEGANS; CELL LOSS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; ENDOPLASMIC RETICULUM; GENE EXPRESSION; GENE SILENCING; GOLGI COMPLEX; HSP GENE; IN VIVO STUDY; MITOCHONDRION; MRP 7 GENE; NERVE DEGENERATION; NEUROMODULATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FOLDING; SENSITIVITY ANALYSIS; STRESS; YOUNG ADULT;

ANIMALIA; CAENORHABDITIS ELEGANS;

METHYLMERCURY; NEURODEGENERATION; NEUROTOXICITY; PARKINSON'S DISEASE;

AMINO ACID SEQUENCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HUMANS; METHYLMERCURY COMPOUNDS; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NERVE DEGENERATION; PRIMARY CELL CULTURE; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84895919687     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12515     Document Type: Article

References (84)

1. Ahringer J., (2006) Reverse genetics. WormBook, 1-43. doi: 10.1895/wormbook.1.47.1.
2. Aleo M. F., Morandini F., Bettoni F., Giuliani R., Rovetta F., Steimberg N., Apostoli P., Parrinello G., and, Mazzoleni G., (2005) Endogenous thiols and MRP transporters contribute to Hg2+ efflux in HgCl2-treated tubular MDCK cells. Toxicology 206, 137-151.
3. Amonpatumrat S., Sakurai H., Wiriyasermkul P., Khunweeraphong N., Nagamori S., Tanaka H., Piyachaturawat P., and, Kanai Y., (2008) L-glutamate enhances methylmercury toxicity by synergistically increasing oxidative stress. J. Pharmacol. Sci. 108, 280-289.
4. Atchison W. D., and, Hare M. F., (1994) Mechanisms of methylmercury-induced neurotoxicity. FASEB J. 8, 622-629.
5. Bakos E., Hegedus T., Hollo Z., Welker E., Tusnady G. E., Zaman G. J., Flens M. J., Varadi A., and, Sarkadi B., (1996) Membrane topology and glycosylation of the human multidrug resistance-associated protein. J. Biol. Chem. 271, 12322-12326.
6. Bianchi L., and, Driscoll M,. (2006) Culture of embryonic C. elegans cells for electrophysiological and pharmacological analyses. WormBook, 1-15. doi: 10.1895/wormbook.1.122.1.
7. Borst P., Evers R., Kool M., and, Wijnholds J., (2000) A family of drug transporters: the multidrug resistance-associated proteins. J. Natl Cancer Inst. 92, 1295-1302.
8. Bortfeld M., Rius M., Konig J., Herold-Mende C., Nies A. T., and, Keppler D., (2006) Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system. Neuroscience 137, 1247-1257.
9. Brenner S., (1974) The genetics of Caenorhabditis elegans. Genetics 77, 71-94.
10. Bridges C. C., Joshee L., and, Zalups R. K., (2011) MRP2 and the handling of mercuric ions in rats exposed acutely to inorganic and organic species of mercury. Toxicol. Appl. Pharmacol. 251, 50-58.
11. Bridges C. C., Joshee L., and, Zalups R. K., (2012) Placental and fetal disposition of mercuric ions in rats exposed to methylmercury: role of Mrp2. Reprod. Toxicol. 34, 628-634.
12. Ceccatelli S., Dare E., and, Moors M., (2010) Methylmercury-induced neurotoxicity and apoptosis. Chem. Biol. Interact. 188, 301-308.
13. Chen Z. S., and, Tiwari A. K., (2011) Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases. FEBS J. 278, 3226-3245.
14. Clarkson T. W., and, Magos L., (2006) The toxicology of mercury and its chemical compounds. Crit. Rev. Toxicol. 36, 609-662.
15. Dallas S., Miller D. S., and, Bendayan R., (2006) Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol. Rev. 58, 140-161.
16. Dean F. B., Nelson J. R., Giesler T. L., and, Lasken R. S., (2001) Rapid amplification of plasmid and phage DNA using Phi 29 DNA polymerase and multiply-primed rolling circle amplification. Genome Res. 11, 1095-1099.
17. Deeley R. G., and, Cole S. P., (2006) Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett. 580, 1103-1111.
18. Della Torre C., Zaja R., Loncar J., Smital T., Focardi S., and, Corsi I., (2012) Interaction of ABC transport proteins with toxic metals at the level of gene and transport activity in the PLHC-1 fish cell line. Chem. Biol. Interact. 198, 9-17.
19. Di Simplicio P., Gorelli M., Vignani R., and, Leonzio C., (1993) The differential modulation of the enzymes of glutathione metabolism. Indication of overlapping effects of toxicity and repair in mouse liver and kidney after dietary treatment with methyl mercury and sodium selenite. Biol. Trace Elem. Res. 36, 167-181.
20. Dreiem A., Shan M., Okoniewski R. J., Sanchez-Morrissey S., and, Seegal R. F., (2009) Methylmercury inhibits dopaminergic function in rat pup synaptosomes in an age-dependent manner. Neurotoxicol. Teratol. 31, 312-317.
21. Drozdzik M., Bialecka M., Mysliwiec K., Honczarenko K., Stankiewicz J., and, Sych Z., (2003) Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics 13, 259-263.
22. Dutheil F., Beaune P., Tzourio C., Loriot M. A., and, Elbaz A., (2010) Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson disease. Arch. Neurol. 67, 739-745.
23. Faro L. R., do Nascimento J. L., Alfonso M., and, Duran R,. (2002) Mechanism of action of methylmercury on in vivo striatal dopamine release. Possible involvement of dopamine transporter. Neurochem. Int. 40, 455-465.
24. Franco J. L., Posser T., Dunkley P. R., et al,. (2009) Methylmercury neurotoxicity is associated with inhibition of the antioxidant enzyme glutathione peroxidase. Free Radic. Biol. Med. 47, 449-457.
25. Frelet A., and, Klein M., (2006) Insight in eukaryotic ABC transporter function by mutation analysis. FEBS Lett. 580, 1064-1084.
26. Furuno T., Landi M. T., Ceroni M., et al,. (2002) Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics 12, 529-534.
27. Goering P. L., Fisher B. R., Noren B. T., Papaconstantinou A., Rojko J. L., and, Marler R. J., (2000) Mercury induces regional and cell-specific stress protein expression in rat kidney. Toxicol. Sci. 53, 447-457.
28. Gotz M. E., Koutsilieri E., Riederer P., Ceccatelli S., and, Dare E., (2002) Methylmercury induces neurite degeneration in primary culture of mouse dopaminergic mesencephalic cells. J. Neural. Transm. 109, 597-605.
29. Guo B. Q., Yan C. H., Cai S. Z., Yuan X. B., and, Shen X. M., (2013) Low level prenatal exposure to methylmercury disrupts neuronal migration in the developing rat cerebral cortex. Toxicology 304, 57-68.
30. Hasegawa K., Miwa S., Isomura K., Tsutsumiuchi K., Taniguchi H., and, Miwa J., (2008) Acrylamide-responsive genes in the nematode Caenorhabditis elegans. Toxicol. Sci. 101, 215-225.
31. Hirrlinger J., Konig J., and, Dringen R., (2002) Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J. Neurochem. 82, 716-719.
32. Hope I,. (1999) C. elegans: A Practical Approach. Oxford University Press, New York.
33. Hunt-Newbury R., Viveiros R., Johnsen R., et al,. (2007) High-throughput in vivo analysis of gene expression in Caenorhabditis elegans. PLoS Biol. 5, e237.
34. Ient B., Edwards R., Mould R., Hannah M., Holden-Dye L., and, O'Connor V., (2012) HSP-4 endoplasmic reticulum (ER) stress pathway is not activated in a C. elegans model of ethanol intoxication and withdrawal. Invert. Neurosci. 12, 93-102.
35. InSug O., Datar S., Koch C. J., Shapiro I. M., and, Shenker B. J., (1997) Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology 124, 211-224.
36. James C. E., and, Davey M. W., (2009) Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans. Int. J. Parasitol. 39, 213-220.
37. Kamath R. S., and, Ahringer J., (2003) Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30, 313-321.
38. Kourtis N., Nikoletopoulou V., and, Tavernarakis N., (2012) Small heat-shock proteins protect from heat-stroke-associated neurodegeneration. Nature 490, 213-218.
39. Lakso M., Vartiainen S., Moilanen A. M., Sirvio J., Thomas J. H., Nass R., Blakely R. D., and, Wong G., (2003) Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J. Neurochem. 86, 165-172.
40. Lam F. C., Liu R., Lu P., Shapiro A. B., Renoir J. M., Sharom F. J., and, Reiner P. B., (2001) beta-Amyloid efflux mediated by p-glycoprotein. J. Neurochem. 76, 1121-1128.
41. Langston J. W,. (1990) Predicting Parkinson's disease. Neurology, 40, 70-74; discussion 75-76.
42. Lania-Pietrzak B., Michalak K., Hendrich A. B., Mosiadz D., Grynkiewicz G., Motohashi N., and, Shirataki Y., (2005) Modulation of MRP1 protein transport by plant, and synthetically modified flavonoids. Life Sci. 77, 1879-1891.
43. Larkin M. A., Blackshields G., Brown N. P., et al,. (2007) ClustalW and ClustalX version 2. Bioinformatics 23, 2947-2948.
44. Lee J., and, Lee J., (2013) Hypoxia-inducible Factor-1 (HIF-1)-independent hypoxia response of the small heat shock protein hsp-16.1 gene regulated by chromatin-remodeling factors in the nematode Caenorhabditis elegans. J. Biol. Chem. 288, 1582-1589.
45. Lee C. G., Tang K., Cheung Y. B., et al,. (2004) MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese. J. Med. Genet. 41, e60.
46. Leslie E. M., Haimeur A., and, Waalkes M. P., (2004) Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). evidence that a tri-glutathione conjugate is required. J. Biol. Chem. 279, 32700-32708.
47. Liao V. H., and, Freedman J. H., (1998) Cadmium-regulated genes from the nematode Caenorhabditis elegans. identification and cloning of new cadmium-responsive genes by differential display. J. Biol. Chem. 273, 31962-31970.
48. Limke T. L., Heidemann S. R., and, Atchison W. D., (2004) Disruption of intraneuronal divalent cation regulation by methylmercury: are specific targets involved in altered neuronal development and cytotoxicity in methylmercury poisoning? Neurotoxicology 25, 741-760.
49. Liu J., Lei D., Waalkes M. P., Beliles R. P., and, Morgan D. L., (2003) Genomic analysis of the rat lung following elemental mercury vapor exposure. Toxicol. Sci. 74, 174-181.
50. Madejczyk M. S., Aremu D. A., Simmons-Willis T. A., Clarkson T. W., and, Ballatori N., (2007) Accelerated urinary excretion of methylmercury following administration of its antidote N-acetylcysteine requires Mrp2/Abcc2, the apical multidrug resistance-associated protein. J. Pharmacol. Exp. Ther. 322, 378-384.
51. Magnarin M., Morelli M., Rosati A., Bartoli F., Candussio L., Giraldi T., and, Decorti G., (2004) Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells. Eur. J. Pharmacol. 483, 19-28.
52. Martin I., Dawson V. L., and, Dawson T. M., (2011) Recent advances in the genetics of Parkinson's disease. Annu. Rev. Genomics Hum. Genet. 12, 301-325.
53. Miller G. W., Gainetdinov R. R., Levey A. I., and, Caron M. G., (1999) Dopamine transporters and neuronal injury. Trends Pharmacol. Sci. 20, 424-429.
54. Moller-Madsen B., (1994) Localization of mercury in CNS of the rat. an autometallographic study. Pharmacol. Toxicol. 75 (Suppl 1), 1-41.
55. Nass R., and, Blakely R. D., (2003) The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration. Annu. Rev. Pharmacol. Toxicol. 43, 521-544.
56. Nass R., and, Przedborski S,. (2008) Parkinson's disease: Molecular and Therapeutic Insights from Model Systems. pp. 652. Elsevier Academic Press, New York.
57. Nass R., Hall D. H., Miller D. M., 3rd, and, Blakely R. D., (2002) Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 99, 3264-3269.
58. Nass R., Merchant K. M., and, Ryan T., (2008) Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need. Mol. Interv. 8, 284-293.
59. Nies A. T., Jedlitschky G., Konig J., Herold-Mende C., Steiner H. H., Schmitt H. P., and, Keppler D., (2004) Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 129, 349-360.
60. Norseth T., and, Clarkson T. W., (1970) Biotransformation of methylmercury salts in the rat studied by specific determination of inorganic mercury. Biochem. Pharmacol. 19, 2775-2783.
61. Novillo A., Won S.-J., Li C., and, Callard I. P., (2005) Changes in Nuclear Receptor and Vitellogenin Gene Expression in Response to Steroids and heavy metal in Caenorhabditis elegans. Integr. Comp. Biol. 45, 61-71.
62. Petersen M. S., Halling J., Bech S., Wermuth L., Weihe P., Nielsen F., Jorgensen P. J., Budtz-Jorgensen E., and, Grandjean P., (2008) Impact of dietary exposure to food contaminants on the risk of Parkinson's disease. Neurotoxicology 29, 584-590.
63. Pratt S., Shepard R. L., Kandasamy R. A., Johnston P. A., Perry W., 3rd, and, Dantzig A. H., (2005) The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol. Cancer Ther. 4, 855-863.
64. Rasband W. S,. (1997-2012) ImageJ. US National Institute of Health, Bethesda, MD, USA. http://localhost/http/::imagej.nih.gov:ij [accessed on 9 December 2009].
65. Reid G., Wielinga P., Zelcer N., De Haas M., Van Deemter L., Wijnholds J., Balzarini J., and, Borst P., (2003) Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol. Pharmacol. 63, 1094-1103.
66. Rozen S., and, Skaletsky H., (2000) Primer3 on the WWW for general users and for biologist programmers, in Bioinformatics Methods and Protocols: Methods in Molecular Biology (, Krawetz S., and, Misener S., eds), pp. 365-386. Humana Press, Totowa, New Jersey.
67. Rudgalvyte M., VanDuyn N., Aarnio V., Heikkinen L., Peltonen J., Lakso M., Nass R., and, Wong G., (2013) Methylmercury exposure increases lipocalin related (lpr) and decreases activated in blocked unfolded protein response (abu) genes and specific miRNAs in Caenorhabditis elegans. Toxicol. Lett. 222, 189-196.
68. Rush T., Liu X., Nowakowski A. B., Petering D. H., and, Lobner D., (2012) Glutathione-mediated neuroprotection against methylmercury neurotoxicity in cortical culture is dependent on MRP1. Neurotoxicology 33, 476-481.
69. Sager P. R., and, Syversen T. L., (1984) Differential responses to methylmercury exposure and recovery in neuroblastoma and glioma cells and fibroblasts. Exp. Neurol. 85, 371-382.
70. Settivari R., Levora J., and, Nass R., (2009) The divalent metal transporter homologues SMF-1/2 mediate dopamine neuron sensitivity in caenorhabditis elegans models of manganism and parkinson disease. J. Biol. Chem. 284, 35758-35768.
71. Settivari R., VanDuyn N., Levora J., and, Nass R., (2013) The Nrf2/SKN-1-dependent glutathione S-transferase pi homologue GST-1 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of manganism. Neurotoxicology 38, 51-60.
72. Sheps J. A., Ralph S., Zhao Z., Baillie D. L., and, Ling V., (2004) The ABC transporter gene family of Caenorhabditis elegans has implications for the evolutionary dynamics of multidrug resistance in eukaryotes. Genome Biol. 5, R15.
73. Tiernan C. T., Edwin E. A., Goudreau J. L., Atchison W. D., and, Lookingland K. J., (2013) The role of de novo catecholamine synthesis in mediating methylmercury-induced vesicular dopamine release from rat pheochromocytoma (PC12) cells. Toxicol. Sci. 133, 125-132.
74. Toyama T., Sumi D., Shinkai Y., Yasutake A., Taguchi K., Tong K. I., Yamamoto M., and, Kumagai Y., (2007) Cytoprotective role of Nrf2/Keap1 system in methylmercury toxicity. Biochem. Biophys. Res. Commun. 363, 645-650.
75. VanDuyn N., Settivari R., Wong G., and, Nass R., (2010) SKN-1/Nrf2 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of methylmercury toxicity. Toxicol. Sci. 118, 613-624.
76. VanDuyn N., Settivari R., Levora J., Zhou S., Unrine J., and, Nass R., (2013) The metal transporter SMF-3/DMT-1 mediates aluminum-induced dopamine neuron degeneration. J. Neurochem. 124, 147-157.
77. Ved R., Saha S., Westlund B., et al,. (2005) Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J. Biol. Chem. 280, 42655-42668.
78. Vistbakka J., VanDuyn N., Wong G., and, Nass R,. (2012) C. elegans as a genetic model system to identify Parkinson's disease-associated therapeutic targets. CNS Neurol. Disord. Drug Targets 11, 957-964.
79. Yamazaki M., Li B., Louie S. W., et al,. (2005) Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport. Xenobiotica 35, 737-753.
80. Yee S., and, Choi B. H., (1996) Oxidative stress in neurotoxic effects of methylmercury poisoning. Neurotoxicology 17, 17-26.
81. Yorifuji T., Tsuda T., Inoue S., Takao S., and, Harada M., (2011) Long-term exposure to methylmercury and psychiatric symptoms in residents of Minamata, Japan. Environ. Int. 37, 907-913.
82. Yu X., Robinson J. F., Sidhu J. S., Hong S., and, Faustman E. M., (2010) A system-based comparison of gene expression reveals alterations in oxidative stress, disruption of ubiquitin-proteasome system and altered cell cycle regulation after exposure to cadmium and methylmercury in mouse embryonic fibroblast. Toxicol. Sci. 114, 356-377.
83. Zalups R. K., and, Bridges C. C., (2009) MRP2 involvement in renal proximal tubular elimination of methylmercury mediated by DMPS or DMSA. Toxicol. Appl. Pharmacol. 235, 10-17.
84. Zeevalk G. D., Razmpour R., and, Bernard L. P., (2008) Glutathione and Parkinson's disease: is this the elephant in the room? Biomed. Pharmacother. 62, 236-249.